| Home | Log In | Register | Our Services | My Account | Contact | Help |
Berkeley Minerals (BMR)
3 monkies - 27 Jan 2011 19:37
kayha - 11 Dec 2013 09:18 - 36 of 47
Click here to listen
js8106455 - 20 Dec 2013 09:48 - 37 of 47
Click here to listen
js8106455 - 20 Dec 2013 15:17 - 38 of 47
galatica - 22 Jan 2014 10:16 - 39 of 47
London (Platts)--21Jan2014/828 am EST/1328 GMT
Goldman Sachs continues to be bullish on zinc, with the market balance predicted to tighten as fresh supply dries up, the bank said Tuesday
As a result the bank raised its 2016 and 2017 LME zinc price forecast to $2,300/mt from $2,200/mt.
"Last month Minmetals announced that one of the world's three largest mines, Century, may close in mid-2015 [6-12 months earlier than anticipated], and that one if its replacement mines -- Dugald River -- was being re-evaluated. We now see the zinc balance tightening more significantly in 2015 and 2016 owing to a lack of supply growth, the bank said.
Goldman's view is common across the market with a raft of banks having published bullish notes over the past six-months.
"Further supporting zinc prices over the next 1-2 years is our [lower] forecasts for gold, silver, and copper prices -- which together make up 60% of zinc miners revenues, followed by 40% from zinc and lead. Lower prices for these commodities would likely constrain zinc concentrate and refined supply growth," the bank said.
Three-month zinc was spot bid on LMEselect as of 1151 GMT at $2,076/mt having closed the Monday kerb session at $2,076.50/mt.
kayha - 14 Feb 2014 13:01 - 40 of 47
Click here to watch
HARRYCAT
- 04 Nov 2014 13:09
- 41 of 47
Suspension
Further to the announcement of Alex Borrelli as Chairman of the Company on 23 October 2014, certain material concerns have come to light as to the classification and valuation of approximately £4.3 million of prepayment for non-current assets as at 31 December 2013. The Company has instructed independent accountants and lawyers to investigate the circumstances underlying these concerns.
The Company has therefore sought and obtained the permission of AIM for trading in its securities on AIM to be suspended forthwith.
The Company has cash balances of approximately £600,000 which represents adequate working capital for its immediate requirements.
mentor - 02 Aug 2016 23:09 - 42 of 47
By Alistair Strang | Tue, 2nd August 2016 - 10:00
AIM-listed miner could be worth 30% more
When we last viewed miner BMR Group (BMR), we were quite optimistic for its future but, as usual, tacked on an illustration warning of criteria for weakness toward 3p with ultimate 1.75p. Thankfully, we proved a wee bit wrong as the share 'only' weakened to 3.1p and now, has enacted something rather more than a classic bounce.
Assuming the company doesn't choose to torpedo the rise by issuing negative news, the situation now is of anything above 5.375 pointing toward 5.575 with secondary 6.35p - maybe 7.5p as the gaps foul our numbers.
While the initial movement to 5.575 sounds useless, this is - from our perspective - a dreadfully important waypoint. Should BMR's mid-price better this level, it should find it hard to avoid growth to 6.35p.
The fly in the cliché is shown with a Dashed Blue line. This is the downtrend since April 2015, created since the share recovered from suspension. Our secondary ambition gives the price of BMR a half-decent chance of closing above this line (5.697p at time of writing) and hopefully entering a new phase of its growth potentials.
We've tacked on a somewhat distant 9.1p at the top of the chart. It would be easy to also display double-digit numbers but realistically, only once BMR actually closes above its last highs of 6.9p will we take them seriously and issue an update. For now, that Dashed Blue line bothers us a little.
Of course, there's always the risk the market treats this with similar contempt to that shown against Gulf Keystone and Xcite Energy. The price of BMR would require actually close below 4.25p before we'd raise an eyebrow as it could easily return to 3p again. With secondary 1.75p!
Bullshare
- 23 Aug 2016 14:46
- 43 of 47
Shares Investor Evenings showcase presentations from leading companies bringing them together in one room.
- Directors present their latest plans regarding development and growth
- An opportunity to talk directly to the companies and personally put forward your questions
- The chance to network with other attendees over drinks and canapés - private investors, wealth managers, fund managers and financial institutions
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Tuesday 27th September 2016
Venue:Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR
Event Timings:| 18.00 | Registration and coffee + More to be announced | |
| 18.30 | Presentations • Manuel Llobet, CEO - Allergy Therapeutics (AGY) • Nick Wykeman, FD - Allergy Therapeutics (AGY) • Alex Borrelli, Chairman & CEO - BMR (BMR) • Jeremy Hawke, Mining & Operations Director - BMR (BMR) • Nick Clarke, Executive Chairman - Central Asia Metals (CAML) • Neil Sinclair, Chief Executive - Palace Capital (PCA) | |
| 20.30 | Drinks reception and canapés | |
| 21.30 | Close |
 | We provide information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy). Allergy vaccination is a successful treatment that deals with the underlying cause of allergies and not just the symptoms! Allergy Therapeutics has a long-term commitment to the development of innovative therapies for allergy treatment and allergy prevention. |
 | BMR has successfully developed a proprietary acid/brine leach process that enables it to achieve high metal recoveries from the different tailings deposits. BMR Group PLC is listed on AIM under the ticker BMR. The Company is focused on the recovery of lead and zinc from the tailings deposits of Zambia’s oldest mine at Kabwe. |
 | Central Asia Metals plc (“CAML” or the “Company”) is an AIM-listed company incorporated in England & Wales, with operational headquarters in London. Its countries of operation are Kazakhstan, Chile and Mongolia. CAML produces copper in Kazakhstan and has a strategic interest in the Copper Bay project in Chile. |
 | Palace Capital is a UK property investment company listed on the Alternative Investment Market (AIM) of The London Stock Exchange. The company is not sector specific and looks for opportunities where we can enhance the long-term income and capital value through asset management and strategic capital development. |
 | RGF is a diversified food business and, following the sale of the Napier Brown sugar business, is focused on three pillar markets; cake decorating, food ingredients and premium bakery. All these markets have the benefit of being spread across a broad spectrum of trade channels: mainstream retail, specialist retail, manufacturing, wholesale, foodservice and export. All are also showing growth. It is proposed that all investment funds, either for capital projects or acquisition, will be focused on building RGF’s scale and presence and in these market sectors. |
Bullshare
- 01 Feb 2017 12:02
- 44 of 47
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Wednesday 15th February 2017
Venue:Radisson Blu Hotel Edinburgh, 80 High Street, The Royal Mile, Edinburgh, EH11TH
Event Timings:| 17.30 | Registration and coffee | |
| 17.55 | Presentations • Alex Borrelli, Chairman & CEO - BMR (BMR) • Jeremy Hawke, Mining & Operations Director - BMR (BMR) • Ed Molyneux, CEO - FreeAgent (FREE) • Michael Hunt, CFO - ReNeuron Group (RENE) • Richard Clemmey, MD - Tertiary Minerals (TYM) • Martin Perrin, CFO - Vipera (VIP) | |
| 20.45 | Drinks reception and canapés | |
| 21.45 | Close |
 | AJ Bell Youinvest is a multi-award winning provider of SIPPs, stocks and shares ISAs, Junior ISAs, Junior SIPPs and share dealing accounts. We offer customers access to a market leading range of investment options, including: shares, funds, ETFs, investment trusts and much more. Our online dealing service starts from just £4.95 and never costs more than £9.95 per deal. |
 | BMR has successfully developed a proprietary acid/brine leach process that enables it to achieve high metal recoveries from the different tailings deposits. BMR Group PLC is listed on AIM under the ticker BMR. The Company is focused on the recovery of lead and zinc from the tailings deposits of Zambia’s oldest mine at Kabwe. |
 | FreeAgent launched in 2007, hewn from the frustration that managing company finances was just too damn hard for most small businesses and freelancers. Since then we’ve doggedly stuck to our mantra of demystifying accounting and redefining the relationship people have with their finances. Ambitious? Sure. Crazy? Quite possibly, but we think it might just work. We’ve won some important awards over the years, but we’re most proud of the lovely things our users say about us, and the super smart and friendly team we’ve built. We’re based in the Scottish capital Edinburgh, recently described as “Probably the most beautiful city we have ever seen” by The Black Eyed Peas! High praise indeed.
|
 | ReNeuron is a leading, clinical-stage cell therapy development business. Based in the UK, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need. ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional immunosuppressive drug treatments. The Company’s therapeutic candidates for stroke disability and critical limb ischaemia are in clinical development and its cell-based treatment for blindness-causing diseases of the retina is currently in pre-clinical development. ReNeuron is also advancing a proprietary platform technology to exploit nanoparticles (exosomes) secreted by stem cells as potential new drug candidates targeting indications in tissue repair, fibrosis and cancer. |
 | Tertiary Minerals plc (ticker symbol 'TYM') is an AIM-traded mineral exploration and development company building a significant strategic position in the fluorspar sector. Fluorspar is an essential raw material in the chemical, steel and aluminium industries with no large scale commercial alternative, or recycling available. Tertiary controls two significant Scandinavian projects (Storuman in Sweden and Lassedalen in Norway) and a large deposit of strategic significance in Nevada USA (MB Project) from which the Company is planning to produce premium grade fluorspar - acid-spar.
|
 | Vipera is a leading provider of mobile financial services platforms. The Vipera platform provides the easiest, fastest, most cost-effective way to develop and operate mobile data services. Solutions powered by Vipera run today on more than 500,000 phones, on hundreds of mobile networks in many countries. Founded in 2005, Vipera has offices in Zurich, Milan and London. |
mentor - 04 Apr 2017 23:03 - 45 of 47
BMR Group recently blotted its copybook but, strangely, we're not yet ringing alarm bells. But we are perhaps justified in wringing our hands together in frustration as the share price has crashed, once again, through its historical glass ceiling. Or perhaps its flat trend line in pink, but "glass ceiling" sounds more techie.
The issue arose following the 10:1 shuffle with BMR's share price, as immediately afterward a glass ceiling at the 7.15p level appeared.
The first time the price broke above this level in October last year, it was permitted a few days in the sun before being trashed for a while. The second time it bettered this level in February this year, it experienced nearly two months in the glow of misplaced optimism before the price was manipulated once again below 7p.
Presumably the company managed to extract some bad news to spoil the immediate potentials.
On the basis that third time will be the charm, if BMR somehow manages close above 7p we'll be fairly comfortable it intends some proper movement as an initial 10.25p makes a lot of sense with secondary, if bettered, at a longer-term 12.25p and the need to re-calculate its potentials as things start to get a bit silly in the growth potential stakes.
For now, we're basing our optimism on the red uptrend line on the chart below.
The share price completed March with a plunge below this red line, perhaps an early warning this trend could be broken. But, importantly, the downward spike happened right at the open courtesy of a manipulation gap and price down spike.
We like down spikes at the open as they "generally but never always" presage some coming upward travel. When they are prefaced with a gap, the subliminal message is a bit Theresa May.
As the closing price inset highlights, it appears the market was keen not to allow BMR to actually close below the uptrend as this would take it into the region of 4.35p initially with secondary a very probable bounce point at 3.85p.
But hope can be taken, as it seems we're not the only folk with a red crayon.
black bird - 14 Jan 2018 14:24 - 46 of 47
HARRYCAT
- 03 Aug 2018 13:24
- 47 of 47
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON
Pursuant to AIM Rule 1 the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.
BMR Group Plc - ORDINARY SHARES OF GBP0.01 EACH, FULLY PAID
| About MoneyAM | Ts and Cs | Privacy Policy | Investment Warning | Content Standards | Corporate Solutions | Advertise With Us | Site Map | © 2025 MoneyAM |
Follow us on Twitter